Illumina Inc. says it is bringing laser-based optical devices to the cosmetic surgery market.
The company says its Illumina Visible Bible and Illumina Illuminate Plastic Surgery, which are made of glass, will be available this fall.
The glasses are designed to absorb light, but they don’t actually emit light, making them more suitable for use in the surgery room, said Illumina president and CEO Thomas Varela.
The company is targeting $100,000 in annual sales of its Illuminate plastic and laser-absorbent lenses, which come in different sizes, and $500,000 of revenue.
Varela says Illumina will launch the new products at a limited number of specialty clinics and hospitals across Canada.
The U.S. market is expected to be the most lucrative.
The $100 million revenue target is for Canada and will be a fraction of what the company had estimated, he said.
The two glasses have already been tested in the U.K. and a trial will be held in the United States in the spring, Varella said.
In a blog post, the company said the glasses are ideal for patients who have problems with the lens, particularly if the lens has been damaged.
The devices also can absorb light from an ultraviolet light source, which is ideal for laser-free surgery.
Verela said the lenses are made with materials that absorb ultraviolet light.
Varenicline is an optical company based in Ontario, Canada.
It is owned by a consortium of U.B.C., Pfizer Inc., and Novartis AG, according to its website.
Virgil Rovira, an associate professor at the University of Toronto’s Osgoode Hall School of Engineering, said he has seen some of the glasses.
He said they were effective for both patients and the staff of the hospital.
The device is not the only technology that has been shown to be effective for surgery, Rovara said.
However, he noted that in the study that Illumina is releasing, a number of the devices tested have been shown in studies to be more effective at removing tissue than lasers.
In addition, Rivin said there is an increasing demand for lasers in surgery.
He said the company has seen a huge uptick in demand in the past few years for these glasses.
“They are being used at the end of the laparoscopic surgeries, they are being applied to the neck surgeries, and they are also being used to remove tumors,” he said in an interview.
He noted that Illumination had been working with several major U.N. organizations on a program to develop safe, reliable lasers.
He added that the UB-University of British Columbia study was done in collaboration with Illumina.
The University of British Colombia’s (UBC) study also looked at a type of laser that absorbs light, called an excimer, which also is not an optical device.
“This is the first time that we have tested an excitable excimer laser, so we’re very excited about this,” Roviras said.
He also said the UBC study has shown that the glasses absorb more than 1,000 lumens per second, which can be useful for a wide range of patients.